ANNE VANLENT Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ANNE VANLENT.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ANNE VANLENT. ANNE VANLENT is Director in I STAT CORPORATION /DE/ ($STAT) and Director in Aviragen Therapeutics, Inc. ($NABI) and Director in QLT INC/BC ($QLTI) and Director in Onconova Therapeutics, Inc. ($ONTX) and Director in APPLIED GENETIC TECHNOLOGIES CORP ($AGTC) and Director in Ocera Therapeutics, Inc. ($TZYM) and Director in Aegerion Pharmaceuticals, Inc. ($AEGR) and Director in Trevi Therapeutics, Inc. ($TRVI).
Latest Insider Trading Transactions of ANNE VANLENT
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AEGR, AGTC, STAT, NVLN, TZYM, ONTX, TRVI, VXRT
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 18 2020 | AGTC | APPLIED GENETIC TE ... | VANLENT ANNE | Director | Option Exercise | A | 4.72 | 12,000 | 56,640 | 12,000 | |
Jun 15 2020 | TRVI | Trevi Therapeutics ... | VANLENT ANNE | Director | Option Exercise | A | 4.10 | 14,210 | 58,261 | 14,210 | |
Dec 06 2019 | AGTC | APPLIED GENETIC TE ... | VANLENT ANNE | Director | Option Exercise | A | 3.02 | 10,000 | 30,200 | 10,000 | |
Jun 14 2019 | AVIR | Vaxart, Inc. | VANLENT ANNE | Director | Option Exercise | A | 0.68 | 12,700 | 8,636 | 12,700 | |
Jun 14 2019 | AVIR | Vaxart, Inc. | VANLENT ANNE | Director | Option Exercise | A | 0.68 | 9,000 | 6,120 | 9,000 | |
May 13 2019 | TRVI | Trevi Therapeutics ... | VANLENT ANNE | Director | Option Exercise | C | 0.00 | 47,807 | 0 | 0 | |
May 13 2019 | TRVI | Trevi Therapeutics ... | VANLENT ANNE | Director | Option Exercise | C | 0.00 | 107,977 | 0 | 0 | |
May 13 2019 | TRVI | Trevi Therapeutics ... | VANLENT ANNE | Director | Buy | P | 10.00 | 5,000 | 50,000 | 25,983 | 21 K to 26 K (+23.83 %) |
May 13 2019 | TRVI | Trevi Therapeutics ... | VANLENT ANNE | Director | Buy | C | 0.00 | 20,983 | 0 | 20,983 | 0 to 21 K |
May 08 2019 | TRVI | Trevi Therapeutics ... | VANLENT ANNE | Director | Option Exercise | A | 10.00 | 23,684 | 236,840 | 23,684 | |
Nov 19 2018 | AGTC | APPLIED GENETIC TE ... | VANLENT ANNE | Director | Option Exercise | A | 6.90 | 10,000 | 69,000 | 10,000 | |
Jul 27 2018 | AGTC | APPLIED GENETIC TE ... | VANLENT ANNE | Director | Option Exercise | A | 4.25 | 8,000 | 34,000 | 8,000 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | VANLENT ANNE | Director | Option Exercise | D | 7.84 | 10,000 | 78,400 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | VANLENT ANNE | Director | Option Exercise | D | 50.88 | 2,652 | 134,934 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | VANLENT ANNE | Director | Option Exercise | D | 48.00 | 2,083 | 99,984 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | VANLENT ANNE | Director | Option Exercise | D | 3.76 | 10,000 | 37,600 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | VANLENT ANNE | Director | Option Exercise | D | 7.85 | 20,000 | 157,000 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | VANLENT ANNE | Director | Option Exercise | D | 2.26 | 12,500 | 28,250 | 0 | |
Dec 11 2017 | TZYM | Ocera Therapeutics ... | VANLENT ANNE | Director | Sell | D | 1.52 | 12,500 | 19,000 | 0 | 12.5 K to 0 (-100.00 %) |
Jun 22 2017 | TZYM | Ocera Therapeutics ... | VANLENT ANNE | Director | Grant | A | 0.00 | 12,500 | 0 | 12,500 | 0 to 12.5 K |
May 22 2017 | AVIR | Aviragen Therapeut ... | VANLENT ANNE | Director | Option Exercise | A | 0.49 | 20,000 | 9,800 | 105,000 | |
Mar 02 2017 | AGTC | APPLIED GENETIC TE ... | VANLENT ANNE | Director | Option Exercise | A | 7.75 | 8,000 | 62,000 | 8,000 | |
Dec 27 2016 | QLTI | NOVELION THERAPEUT ... | VANLENT ANNE | Director | Option Exercise | A | 8.65 | 9,600 | 83,040 | 9,600 | |
Dec 01 2016 | QLTI | QLT INC/BC | VANLENT ANNE | Director | Grant | A | 0.00 | 4,102 | 0 | 4,102 | 0 to 4.1 K |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | VANLENT ANNE | Director | Option Exercise | D | 17.98 | 18,000 | 323,640 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | VANLENT ANNE | Director | Option Exercise | D | 32.55 | 5,012 | 163,141 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | VANLENT ANNE | Director | Option Exercise | D | 37.66 | 14,700 | 553,602 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | VANLENT ANNE | Director | Sell | D | 0.00 | 4,000 | 0 | 0 | 4 K to 0 (-100.00 %) |
Aug 18 2016 | AGTC | APPLIED GENETIC TE ... | VANLENT ANNE | Director | Option Exercise | A | 15.13 | 16,000 | 242,080 | 16,000 | |
Jun 15 2016 | TZYM | Ocera Therapeutics ... | VANLENT ANNE | Director | Option Exercise | A | 2.26 | 12,500 | 28,250 | 12,500 | |
May 13 2016 | NABI | Aviragen Therapeut ... | VANLENT ANNE | Director | Option Exercise | A | 1.50 | 20,000 | 30,000 | 20,000 | |
Aug 13 2015 | NABI | Aviragen Therapeut ... | VANLENT ANNE | Director | Option Exercise | A | 2.49 | 5,000 | 12,450 | 5,000 | |
Jun 29 2015 | AEGR | Aegerion Pharmaceu ... | VANLENT ANNE | Director | Option Exercise | A | 17.98 | 18,000 | 323,640 | 18,000 | |
Jun 24 2015 | NABI | Aviragen Therapeut ... | VANLENT ANNE | Director | Buy | P | 2.20 | 35,000 | 76,892 | 35,000 | 0 to 35 K |
Jun 22 2015 | TZYM | Ocera Therapeutics ... | VANLENT ANNE | Director | Option Exercise | A | 3.76 | 10,000 | 37,600 | 10,000 | |
Jun 17 2015 | ONTX | Onconova Therapeut ... | VANLENT ANNE | Director | Option Exercise | A | 2.69 | 10,000 | 26,900 | 10,000 | |
May 14 2015 | NABI | Aviragen Therapeut ... | VANLENT ANNE | Director | Option Exercise | A | 2.20 | 15,000 | 33,000 | 15,000 | |
Jan 30 2004 | STAT | I STAT CORPORATION ... | VANLENT ANNE | Director | Option Exercise | M | 6.59 | 6,230 | 41,056 | 0 | |
Jan 30 2004 | STAT | I STAT CORPORATION ... | VANLENT ANNE | Director | Option Exercise | M | 5.08 | 10,256 | 52,100 | 0 | |
Jan 30 2004 | STAT | I STAT CORPORATION ... | VANLENT ANNE | Director | Option Exercise | M | 13.00 | 3,737 | 48,581 | 0 | |
Jan 30 2004 | STAT | I STAT CORPORATION ... | VANLENT ANNE | Director | Option Exercise | M | 9.75 | 4,876 | 47,541 | 0 | |
Jan 30 2004 | STAT | I STAT CORPORATION ... | VANLENT ANNE | Director | Sell | U | 15.35 | 6,230 | 95,631 | 0 | 6.2 K to 0 (-100.00 %) |
Jan 30 2004 | STAT | I STAT CORPORATION ... | VANLENT ANNE | Director | Buy | M | 6.59 | 6,230 | 41,056 | 6,230 | 0 to 6.2 K |
Jan 30 2004 | STAT | I STAT CORPORATION ... | VANLENT ANNE | Director | Sell | U | 15.35 | 10,256 | 157,430 | 0 | 10.3 K to 0 (-100.00 %) |
Jan 30 2004 | STAT | I STAT CORPORATION ... | VANLENT ANNE | Director | Buy | M | 5.08 | 10,256 | 52,100 | 10,256 | 0 to 10.3 K |
Jan 30 2004 | STAT | I STAT CORPORATION ... | VANLENT ANNE | Director | Sell | U | 15.35 | 3,737 | 57,363 | 0 | 3.7 K to 0 (-100.00 %) |
Jan 30 2004 | STAT | I STAT CORPORATION ... | VANLENT ANNE | Director | Buy | M | 13.00 | 3,737 | 48,581 | 3,737 | 0 to 3.7 K |
Jan 30 2004 | STAT | I STAT CORPORATION ... | VANLENT ANNE | Director | Sell | U | 15.35 | 4,876 | 74,847 | 0 | 4.9 K to 0 (-100.00 %) |
Jan 30 2004 | STAT | I STAT CORPORATION ... | VANLENT ANNE | Director | Buy | M | 9.75 | 4,876 | 47,541 | 4,876 | 0 to 4.9 K |
Jan 30 2004 | STAT | I STAT CORPORATION ... | VANLENT ANNE | Director | Sell | U | 15.35 | 19,264 | 295,702 | 0 | 19.3 K to 0 (-100.00 %) |
Page: 1